Focus: PUR Biologics is a publicly traded orthobiologics company headquartered in Irvine, CA, founded in 2018 with a pipeline spanning neurology and gastroenterology. The company operates at a modest scale with 5 active job openings.
Profile data last refreshed 28m ago · AI intelligence enriched 1w ago
Stable — net +1 jobs in 30d
8 added, 7 removed. Backfill posture.
A speculative early-stage public biotech with opaque pipeline and financials; suitable only for risk-tolerant candidates willing to bet on orthobiologics thesis without evidence of clinical or commercial traction.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for PUR Biologics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from PUR Biologics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles